Tao Li

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cross Sectional

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Drug Administration

Top Venues

Technology in cancer research & treatment

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Li, Chao Chen, Lu Liu, Jiapei Qin, Lupeng Qiu, An Wang, Weiwei Dong, Gehan Zhang, Yao Li, Lei Zhao, Fan Zhang, Yi Hu
A multicenter, real-world study on effectiveness and safety of first-line modified PD-1 inhibitors with chemotherapy in advanced non-small cell lung cancer (aNSCLC) with drive gene-negative. Cancer medicine 13 (3) (2024)
Tao Li, Chao Chen, Lu Liu, Jiapei Qin, Lupeng Qiu, An Wang, Weiwei Dong, Gehan Zhang, Yao Li, Lei Zhao, Fan Zhang, Yi Hu
A multicenter, real-world study on effectiveness and safety of first-line modified PD-1 inhibitors with chemotherapy in advanced non-small cell lung cancer (aNSCLC) with drive gene-negative. Cancer medicine 13 (3) (2024)
Tao Li, Chao Chen, Lu Liu, Jiapei Qin, Lupeng Qiu, An Wang, Weiwei Dong, Gehan Zhang, Yao Li, Lei Zhao, Fan Zhang, Yi Hu
A multicenter, real-world study on effectiveness and safety of first-line modified PD-1 inhibitors with chemotherapy in advanced non-small cell lung cancer (aNSCLC) with drive gene-negative. Cancer medicine 13 (3) (2024)
Tao Li, Wen-Yu Yang, Ting-Ting Liu, Yao Li, Lu Liu, Xuan Zheng, Lei Zhao, Fan Zhang, Yi Hu
Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China. Technology in cancer research & treatment 22 (2023)
Tao Li, Wen-Yu Yang, Ting-Ting Liu, Yao Li, Lu Liu, Xuan Zheng, Lei Zhao, Fan Zhang, Yi Hu
Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China. Technology in cancer research & treatment 22 (2023)
Lu Liu, Chunsun Li, Zhen Wu, Yanqin Li, Hang Yu, Tao Li, Yueming Wang, Wei Zhao, Liangan Chen
LCMR1 Promotes Large-Cell Lung Cancer Proliferation and Metastasis by Downregulating HLA-Encoding Genes. Cancers 15 (22) (2023)
Tao Li, Wen-Yu Yang, Ting-Ting Liu, Yao Li, Lu Liu, Xuan Zheng, Lei Zhao, Fan Zhang, Yi Hu
Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China. Technology in cancer research & treatment 22 (2023)